Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of β-thalassemia intermedia
P. Schmidt, T. Racie, M. Westerman, K. Fitzgerald, James S. Butler, M. Fleming
American journal of hematology/oncology